摘要:
The invention concerns oxadiazole derivatives of general formula (I) in which X, Y, Z and R1 have the definitions given in the description and the claims. The invention further concerns processes for preparing these substances and their use as medicaments.
摘要:
The application relates to substituted 2,3,3a,4,9,9a hexahydro-8-hydroxy-1H-benz[f]indole derivatives, to a method for the production thereof, and to their use as medicaments. The inventive indole derivatives correspond to general formula (1).
摘要:
The invention relates to N-(5-phenyl-tetrahydrofuranyl)methyl-and N-(6-phenyl-tetrahydropyranyl)methyl substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols of general formula (1), to a method for producing them and to their use as medicaments.
摘要:
The invention relates to novel substituted 1,2,3,4,5,6-hexahydro-2.6-methano-3-benzazocine-10-oles of general formula (I), and to a method for the production and the use thereof as medicaments.
摘要:
The invention relates to novel substituted 3-phenoxy or 3-phenylalkyloxy-2-phenyl-propylamines of general formula (1), to methods for producing them and to their use as medicaments.
摘要:
The invention relates to the use of triazolones as medicaments, especially as medicaments with a neuroprotective action, to novel triazolones and to methods for producing them.
摘要:
The invention relates to N-(5-phenyl-tetrahydrofuranyl)methyl-and N-(6-phenyl-tetrahydropyranyl)methyl substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols of general formula (1), to a method for producing them and to their use as medicaments.
摘要:
The invention relates to novel diphenyl-substituted 6-ring-heterocycles of general formula (I), wherein A, X and the radicals R?1, R2, R3, R4 and R5¿ have the meanings given in the description. The invention also relates to methods for producing the inventive compounds and to their use as medicaments.
摘要:
L'invention concerne des cyclopeptides ayant la formule générale (I) et leurs sels, les résidus d'acides aminés An à Kn ayant la notation donnée dans la description, ainsi que leur production et leur utilisation. Ces nouveaux composés sont des agonistes d'ANP.
摘要:
The invention concerns oxadiazole derivatives of general formula (I) in which X, Y, Z and R1 have the definitions given in the description and the claims. The invention further concerns processes for preparing these substances and their use as medicaments.